Privia Health to Report First Quarter 2021 Results on Thursday, May 27th
ARLINGTON, Va., May 11, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to...
Day: May 11, 2021
Alberta Project Explores Use of Synthetic Data as Alternative to Health Data Utilization
Merck Canada Joins Synthetic Data ProjectEDMONTON, Alberta, May 11, 2021 (GLOBE NEWSWIRE) -- Health City and the Institute of Health...
The Good Patch Partners with Ulta Beauty to Bring Plant-based Wellness Patches Directly to Customers
In addition, Ulta will serve as the retail launch partner to bring The Good Patch’s newest patch, Relax, to brick-and-mortar...
MannKind Corporation to Participate in 2021 RBC Capital Markets Global Healthcare Conference
WESTLAKE VILLAGE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and...
EXMceuticals Inc is Pleased to Announce the Signing of the Definitive Business Combination Agreement with Global Cannabinoids and Launch of its up-to $6,000,000 CAD Private Placement
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE)...
HealthEquity Sets Date to Announce First Quarter Results
DRAPER, Utah, May 11, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA...
Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient...
Allied Sells Out First Colombian Harvest and Begins to Rapidly Scale Colombian Production
KELOWNA, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
HEXO Corp Announces At-the-Market Offering of up to C$150,000,000
OTTAWA, May 11, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is pleased to...
RNA Disease Diagnostics Announces Inaugural Joint Meeting of Expanded Board of Directors and Advisory Board
BALTIMORE, May 11, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform...
The ALS Association Massachusetts Chapter Hosts Inaugural “CEO Soak” on June 10 in Downtown Boston
Event Builds on Ice Bucket Challenge Legacy to Raise Funds for Local Families Living with ALSNORWOOD, Mass., May 11, 2021...
SOTIO to Present Biomarker Data from its SOV01 – DCVAC/OvCa Phase 2 Study in 1st line Ovarian Cancer at the 2021 ASCO Annual Meeting
PRAGUE, Czech Republic, May 11, 2021 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immune-oncology company owned by PPF Group, today...
AzurRx BioPharma to Present at the Emerging Growth Conference (May 12)
DELRAY BEACH, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical...
Resonant to Present at 16th Annual Needham Virtual Technology & Media Conference on May 19th
AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions...
SCYNEXIS Appoints Accomplished Commercial Executive Christine Coyne as Chief Commercial Officer to Lead the Brexafemme® Launch
Strengthening the management team with deep anti-infective commercial expertise across hospital and community settings ahead of anticipated approval of Brexafemme...
Bellerophon Provides Clinical Program Update and Reports First Quarter 2021 Financial Results
WARREN, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2021 Financial Results on Monday May 17, 2021
BEVERLY HILLS, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (Nasdaq:TOMZ), a global company specializing in...
Biosight Completes Enrollment in Phase 2b Study of Aspacytarabine (BST-236) for First-Line Acute Myeloid Leukemia Therapy
Encouraging data support single-agent efficacy across key measures including complete remission (CR) with negative minimal residual disease (MRD) rates, duration...
Akouos Presents Nonclinical Data Supporting Future Clinical Development of AK-OTOF and AK-antiVEGF at the American Society of Gene and Cell Therapy 24th Annual Meeting
- Intracochlear delivery of a dual AAVAnc80 vector encoding human otoferlin results in full-length protein expression in inner hair cells...
Golden Leaf to Present at Canaccord Genuity’s Virtual Conference
PORTLAND, Ore., May 11, 2021 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the...